Skip to main content
OpenTrials
Completed

NCT Number: NCT01208532

Validation Study of the Korean Version of the EORTC QLQ-HDC29

The aim of this study is to evaluate the reliability and validity of the Korean version of the European Organization for Research and Treatment of Cancer High-dose Chemotherapy module (EORTC HDC-29).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Quality of Life After Stem Cell Transplantation

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Hospital

Seoul, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who are aged more than 18 years
  • Patients who are diagnosed with hematologic malignancies and who are planned to receive high-dose chemotherapy followed by allogeneic or autologous stem cell transplantation (SCT)
  • Patients who agree with the informed consent

Exclusion criteria

  • Patients who are unable to complete the questionnaire due to the serious physical or psychological morbidity

Treatment and study plan

Primary outcomes

  1. Reliability and validity of the Korean version of the EORTC HDC-29

    Time frame: at the patient's hospitalization (before the SCT) and the outpatient clinic (three, six, and 12 months after their SCT)

    Relaibility; Cronbach's alpha coefficient is used to evaluate the internal consistency.

    Validity; Persons's correlation coefficient is used to examine the correlation between similar dimensions of the different questionnaires.

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

Quality of Life in Patients With Stem Cell Transplant After High Dose Chemotherapy: Validation Study of the Korean Version of the EORTC QLQ-HDC29

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Sep 24, 2010
Registry last updated
Apr 23, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.